The effect of a bioactive collagen membrane releasing PDGF or GDF-5 on bone regeneration

Biomaterials

Volumn 35, Issue 8, 2014, Pages 2446-2453

  Yamano, Seiichi ^a   Haku, Ken ^a   Yamanaka, Takuto ^a   Dai, Jisen ^a   Takayama, Tadahiro ^a   Shohara, Ryutaro ^a   Tachi, Keita ^a   Ishioka, Mika ^a   Hanatani, Shigeru ^a   Karunagaran, Sanjay ^b   Wada, Keisuke ^c   Moursi, Amr M ^a  

^a NEW YORK UNIVERSITY COLLEGE OF DENTISTRY   (United States)

^b UNIVERSITY OF TENNESSEE HEALTH SCIENCE CENTER   (United States)

^c UNIVERSITY OF PENNSYLVANIA SCHOOL OF DENTAL MEDICINE   (United States)

Author keywords

Bone regeneration; Collagen membrane; GDF 5; Growth factor; PDGF

Indexed keywords

BONE REGENERATION; COLLAGEN MEMBRANE; GDF-5; GROWTH FACTOR; PDGF;

CELL PROLIFERATION; COLLAGEN; DEFECTS; GENE EXPRESSION; MEMBRANE TECHNOLOGY; PHOSPHATASES; SURGERY;

BONE;

ALKALINE PHOSPHATASE; COLLAGEN; GROWTH DIFFERENTIATION FACTOR 5; OSTEOCALCIN; PLATELET DERIVED GROWTH FACTOR; TRANSCRIPTION FACTOR RUNX2;

ANIMAL CELL; ARTICLE; BONE DEFECT; BONE REGENERATION; CELL PROLIFERATION; CELL VIABILITY; COMPARATIVE STUDY; CONTROLLED STUDY; CYTOTOXICITY; GENE EXPRESSION; MARKER GENE; MEMBRANE; MEMBRANE TECHNOLOGY; MICRO-COMPUTED TOMOGRAPHY; MOUSE; NONHUMAN; OSSIFICATION; OSTEOBLAST; PRIORITY JOURNAL;

RATTUS;

BONE REGENERATION; COLLAGEN MEMBRANE; GDF-5; GROWTH FACTOR; PDGF;

3T3 CELLS; ALKALINE PHOSPHATASE; ANIMALS; BONE REGENERATION; CELL PROLIFERATION; CELL SURVIVAL; COLLAGEN; GENE EXPRESSION; GROWTH DIFFERENTIATION FACTOR 5; MICE; OSTEOCALCIN; OSTEOGENESIS; PLATELET-DERIVED GROWTH FACTOR; RATS; TRANSCRIPTION FACTORS;

EID: 84891742692     PISSN: 01429612     EISSN: 18785905     Source Type: Journal    
DOI: 10.1016/j.biomaterials.2013.12.006     Document Type: Article

References (46)

1. Moore Y.R., Dickinson D.P., Wikesjö U.M. Growth/differentiation factor-5: a candidate therapeutic agent for periodontal regeneration? A review of pre-clinical data. JClin Periodontol 2010, 37:288-298.
2. Hötten G., Neidhardt H., Jacobowsky B., Pohl J. Cloning and expression of recombinant human growth/differentiation factor 5. Biochem Biophys Res Commun 1994, 204:646-652.
3. Faiyaz-Ul-Haque M., Ahmad W., Wahab A., Haque S., Azim A.C., Zaidi S.H., et al. Frameshift mutation in the cartilage-derived morphogenetic protein 1 (CDMP1) gene and severe acromesomelic chondrodysplasia resembling Grebe-type chondrodysplasia. Am J Med Genet 2002, 111:31-37.
4. Settle S.H., Rountree R.B., Sinha A., Thacker A., Higgins K., Kingsley D.M. Multiple joint and skeletal patterning defects caused by single and double mutations in the mouse Gdf6 and Gdf5 genes. Dev Biol 2003, 254:116-130.
5. Sena K., Morotome Y., Baba O., Terashima T., Takano Y., Ishikawa I. Gene expression of growth differentiation factors in the developing periodontium of rat molars. JDent Res 2003, 82:166-171.
6. Spiro R.C., Liu L., Heidaran M.A., Thompson A.Y., Ng C.K., Pohl J., et al. Inductive activity of recombinant human growth and differentiation factor-5. Biochem Soc Trans 2000, 28:362-368.
7. Emerton K.B., Drapeau S.J., Prasad H., Rohrer M., Roffe P., Hopper K., et al. Regeneration of periodontal tissues in non-human primates with rhGDF-5 and beta-tricalcium phosphate. JDent Res 2011, 90:1416-1421.
8. Yoshimoto T., Yamamoto M., Kadomatsu H., Sakoda K., Yonamine Y., Izumi Y. Recombinant human growth/differentiation factor-5 (rhGDF-5) induced bone formation in murine calvariae. JPeriodont Res 2006, 41:140-147.
9. Gruber R.M., Ludwig A., Merten H.A., Achilles M., Poehling S., Schliephake H. Sinus floor augmentation with recombinant human growth and differentiation factor-5 (rhGDF-5): a histological and histomorphometric study in the Goettingen miniature pig. Clin Oral Implants Res 2008, 19:522-529.
10. Weng D., Poehling S., Pippig S., Bell M., Richter E.J., Zuhr O., et al. The effects of recombinant human growth/differentiation factor-5 (rhGDF-5) on bone regeneration around titanium dental implants in barrier membrane-protected defects: a pilot study in the mandible of beagle dogs. Int J Oral Maxillofac Implants 2009, 24:31-37.
11. Schwarz F., Rothamel D., Heeten M., Ferrari D., Sager M., Becker J. Lateral ridge augmentation using particulated or block bone substitutes biocoated with rhGDF-5 and rhBMP-2: an immunohistochemical study in dogs. Clin Oral Implants Res 2008, 19:642-652.
12. Kwon H.R., Wikesjö U.M., Park J.C., Kim Y.T., Bastone P., Pippig S.D., et al. Growth/differentiation factor-5 significantly enhances periodontal wound healing/regeneration compared with platelet-derived growth factor-BB in dogs. JClin Periodontol 2010, 37:739-746.
13. Barrientos S., Stojadinovic O., Golinko M.S., Brem H., Tomic-Canic M. Growth factors and cytokines in wound healing. Wound Repair Regen 2008, 16:585-601.
14. Anusaksathien O., Jin Q., Zhao M., Somerman M.J., Giannobile W.V. Effect of sustained gene delivery of platelet-derived growth factor or its antagonist (PDGF-1308) on tissue-engineered cementum. JPeriodontol 2004, 75:429-440.
15. Nevins M.L., Camelo M., Nevins M., Schupbach P., Friedland B., Camelo J.M., et al. Minimally invasive alveolar ridge augmentation procedure (tunneling technique) using rhPDGF-BB in combination with three matrices: a case series. Int J Periodontics Restorative Dent 2009, 29:371-383.
16. Young C.S., Ladd P.A., Browning C.F., Thompson A., Bonomo J., Shockley K., et al. Release, biological potency, and biochemical integrity of recombinant human platelet-derived growth factor-BB (rhPDGF-BB) combined with AugmentTM bone graft or GEM 21S beta-tricalcium phosphate (b-TCP). JControl Release 2009, 140:250-255.
17. Stavropoulos A., Windisch P., Gera I., Capsius B., Sculean A., Wikesjö U.M. Aphase IIa randomized, controlled, clinical and histological pilot study evaluating rhGDF-5/β-TCP for periodontal regeneration. JClin Periodontol 2011, 38:1044-1054.
18. Britain S.K., Arx Tv, Schenk R.K., Buser D., Nummikoski P., Cochran D.L. The use of guided tissue regeneration principles in endodontic surgery for induced chronic periodontic-endodontic lesions: a clinical, radiographic, and histologic evaluation. JPeriodontol 2005, 76:450-460.
19. Gouldin A.G., Fayad S., Mellonig J.T. Evaluation of guided tissue regeneration in interproximal defects: (II)-membrane and bone versus membrane alone. JClin Periodontol 1996, 23:485-491.
20. Wang H.L., O'Neal R.B., Thomas C.L., Shyr Y., MacNeil R.L. Evaluation of an absorbable collagen membrane in treating Class II furcation defects. JPeriodontol 1994, 65:1029-1036.
21. Christgau M., Schmalz G., Reich E., Wenzel A. Clinical and radiographical splitmouth-study on resorbable versus non-resorbable GTR-membranes. JClin Periodontol 1995, 22:306-315.
22. Douthitt J.C., Gutmann J.L., Witherspoon D.E. Histologic assessment of healing after the use of a bioresorbable membrane in the management of buccal bone loss concomitant with periradicular surgery. JEndod 2001, 27:404-410.
23. Tsesis I., Rosen E., Tamse A., Taschieri S., Del Fabbro M. Effect of guided tissue regeneration on the outcome of surgical endodontic treatment: a systematic review and meta-analysis. JEndod 2011, 37:1039-1045.
24. Bunyaratavej P., Wang H.L. Collagen membranes: a review. JPeriodontol 2001, 72:215-229.
25. Machtei E.E., Cho M.I., Dunford R., Norderyd J., Zambon J.J., Genco R.J. Clinical, microbiological and histological factors which influence the success of regenerative periodontal therapy. JPeriodontol 1994, 65:154-161.
26. Wikesjö U.M., Sigurdsson T.J., Lee M.B., Tatakis D.N., Selvig K.A. Dynamics of wound-healing in regenerative periodontal therapy. JCalif Dent Assoc 1995, 23:30-35.
27. Stoecklin-Wasmer C., Rutjes A.W., da Costa B.R., Salvi G.E., Jüni P., Sculean A. Absorbable collagen membranes for periodontal regeneration: a systematic review. JDent Res 2013, 92:773-781.
28. Yamano S., Lin T.Y., Dai J., Fabella K., Moursi A.M. Bioactive collagen membrane as a carrier of sustained release of PDGF. JTissue Sci Eng 2011, 2:110.
29. Dai J., Jian J., Bosland M., Frenkel K., Bernhardt G., Huang X. Roles of hormone replacement therapy and iron in proliferation of breast epithelial cells with different estrogen and progesterone receptor status. Breast 2008, 17:172-179.
30. Artzi Z., Givol N., Rohrer M.D., Nemcovsky C.E., Prasad H.S., Tal H. Qualitative and quantitative expression of bovine bone mineral in experimental bone defects. Part 1: description of a dog model and histological observations. JPeriodontol 2003, 74:1143-1152.
31. Sato R., Matsuzaka K., Kokubu E., Inoue T. Immediate loading after implant placement following tooth extraction up-regulates cellular activity in the dog mandible. Clin Oral Implants Res 2011, 22:1372-1378.
32. Cao L., Mooney D.J. Spatiotemporal control over growth factor signaling for therapeutic neovascularization. Adv Drug Deliv Rev 2007, 59:1340-1350.
33. Gerstenfeld L.C., Cullinane D.M., Barnes G.L., Graves D.T., Einhorn T.A. Fracture healing as a post-natal developmental process: molecular, spatial, and temporal aspects of its regulation. JCell Biochem 2003, 88:873-884.
34. Zeng Q., Li X., Beck G., Balian G., Shen F.H. Growth and differentiation factor-5 (GDF-5) stimulates osteogenic differentiation and increases vascular endothelial growth factor (VEGF) levels in fat-derived stromal cells invitro. Bone 2007, 40:374-381.
35. Nishimura R., Hata K., Matsubara T., Wakabayashi M., Yoneda T. Regulation of bone and cartilage development by network between BMP signalling and transcription factors. JBiochem 2012, 15:247-254.
36. Komori T. Signaling networks in Runx2-dependent bone development. JCell Biochem 2011, 112:750-755.
37. Matsubara K., Kida K., Yamaguchi A., Hata K., Ichida F., Meguro H., et al. BMP2 regulates osterix through Msx2 and Runx2 during osteoblast differentiation. JBiol Chem 2008, 283:29119-29125.
38. Ducy P., Zhang R., Geoffroy V., Ridall A.L., Karsenty G. Osf2/Cbfa1: a transcription activator of osteoblast differentiation. Cell 1997, 89:747-754.
39. Ruskin J.D., Hardwick R., Buser D., Dahlin C., Schenk R.K. Alveolar ridge repair in a canine model using rhTGF-β1 with barrier membranes. Clin Oral Implants Res 2000, 11:107-115.
40. Kim Y.T., Wikesjö U.M., Jung U.W., Lee J.S., Kim T.G., Kim C.K. Comparison between a β-tricalcium phosphate and an absorbable collagen sponge carrier technology for recombinant human growth/differentiation factor-5 stimulated periodontal wound healing/regeneration. JPeriodontol 2012, 84:812-820.
41. Kaban L.B., Glowacki J. Induced osteogenesis in the repair of experimental mandibular defects in rats. JDent Res 1981, 60:1356-1364.
42. Schmitz J.P., Hollinger J.O. The critical size defect as an experimental model for craniomandibulofacial nonunions. Clin Orthop Relat Res 1986, 205:299-308.
43. Kanczler J.M., Oreffo R.O. Osteogenesis and angiogenesis: the potential for engineering bone. Eur Cell Mater 2008, 15:100-114.
44. Patino M.G., Neiders M.E., Andreana S., Noble B., Cohen R.E. Collagen as an implantable material in medicine and dentistry. JOral Implantol 2002, 28:220-225.
45. Gold man R. Growth factor and chronic wound healing: past, present, future. Adv Skin Wound Care 2004, 17:24-35.
46. Zhang B.O., Yang S., Sun Z., Zhang Y., Xia T., Xu W., et al. Human mesenchymal stem cells induced by growth differentiation factor 5: an improved self-assembly tissue engineering method for cartilage repair. Tissue Eng 2011, 17:1189-1199.